首页   按字顺浏览 期刊浏览 卷期浏览 Nitrofurantoin-Induced Immune-Mediated Lung and Liver Disease
Nitrofurantoin-Induced Immune-Mediated Lung and Liver Disease

 

作者: A. Schattner,   J. Von der Walde,   N. Kozak,   N. Sokolovskaya,   H. Knobler,  

 

期刊: The American Journal of the Medical Sciences  (OVID Available online 1999)
卷期: Volume 317, issue 5  

页码: 336-336

 

ISSN:0002-9629

 

年代: 1999

 

出版商: OVID

 

关键词: Nitrofurantoin;Toxicity nitrofurantoin;Adverse drug reaction interstitial lung disease;Drug-induced liver disease;Drug-induced chronic active hepatitis

 

数据来源: OVID

 

摘要:

A 60-year-old woman with multiple sclerosis and recurrent urinary tract infections (UTI) was evaluated for the recent onset of a dry cough, dyspnea on exertion, and jaundice. Investigation demonstrated interstitial lung disease with bilateral infiltrates and unilateral effusion, as well as a severe chronic active hepatitis with marked fibrosis. Other notable features were positive antinuclear antibodies and anti-smooth-muscle antibodies and the absence of any possible cause except for nitrofurantoin treatment (Macrodantin, 100 mg/day), which the patient had been taking for the previous 3 years as a prophylactic measure against UTI. The patient died of pneumococcal septicemia less than 30 days after presentation. Pulmonary or hepatic injury caused by nitrofurantoin treatment is rare; their combined occurrence is hardly ever described. Combined drug-induced pulmonary and hepatic toxicity is reviewed and should be considered early in the differential diagnosis to allow reversibility and avoid serious outcomes.

 



返 回